compensated research study that clinicians caring for children with asthma on controller medications
Posted 5 days ago by Michelle Wade
Dear Colleague,
I'm writing to you at the request of Dr. Stephen Teach from the University of Vermont Larner College of Medicine. I wanted to make you aware of a compensated research study that clinicians caring for children with asthma on controller medications in Vermont might find interesting. For more information, please read the following message from the Principal Investigator of the study at UVM, Dr. Stephen Teach.
Sincerely, Michelle
Dear VNPA Members:
I invite you to voluntarily participate in a compensated research project which seeks to identify barriers and facilitators to school-based asthma therapy among Vermont’s schoolchildren. The project is supported by a grant from the Leahy Institute for Rural Partnerships at the University of Vermont.
School-based asthma therapy (SBAT) is a relatively new approach to providing daily medications to children with asthma that require them. Instead of receiving morning doses of daily controller medications at home, children receive them on school days from the school nurse in the school nursing suite. This is in addition to reliever medications like albuterol that school nurses might administer for cough or wheezing on an as-needed basis. Studies of children who receive SBAT in urban schools have shown improved asthma outcomes. Our project seeks to explore it in a rural setting.
Your participation would include a virtual interview using the Teams application with one of our clinical research staff. We will ask you a series of specific questions to help us understand how school-based asthma therapy might work from your perspective. This interview will last less than 60 minutes. Participants will receive $100 in compensation.
If you wish to participate, contact our study team at sbat@uvm.edu.
Best Regards,
Dr. Stephen Teach
University of Vermont Larner College of Medicine